Maternal and Child Health Policy Innovation Program (MCH PIP)

Maternal and Child Health Policy Innovation Program (MCH PIP) is sponsored by Health Resources and Services Administration (HRSA). This program supports innovative city, county, or state-level policy initiatives that improve outcomes and reduce associated health disparities for maternal and child health populations. Award recipients will provide technical assistance to stakeholders to help them develop and implement policy initiatives.

U.S. Department of Health and Human Services ## NOTICE OF FUNDING OPPORTUNITY ## Maternal and Child Health Bureau ## Office of Policy and Planning ## Maternal and Child Health Policy Innovation Program ## Funding Opportunity Number: HRSA-24-037 ## Funding Opportunity Type(s): Competing Continuation, New ## Assistance Listing Number: 93. 110 # Application Due Date: July 10, 2024 Ensure your SAM. gov and Grants.

gov registrations and passwords are current immediately! We will not approve deadline extensions for lack of registration. Registration in all systems may take up to 1 month to complete.

Issuance Date: April 26, 2024 ## Modification Date: May 16, 2024 ## See next page for details! Public Health Analyst, Office of Policy and Planning See Section VII for a complete list of agency contacts. Authority: 42 U.S.C.

§ 701(a)(2) (§ 501(a)(2) of the Social Security Act) HRSA-24-037 MCH PIP i # 508 COMPLIANCE DISCLAIMER Persons using assistive technology may not be able to fully access information in this file. For assistance, email or call one of the HRSA staff listed in Section VII Agency # MAY 16, 2024, MODIFICATION DETAILS*: • Clarified eligible applicants in SUMMARY and Section III. 3.

1. Eligible • Shifted the period of performance forward. • Added clarifying details in Section V.

2. Review and Selection Process *New text highlighted yellow . Funding Opportunity Title: Maternal and Child Health Policy Innovation Funding Opportunity Number: HRSA-24-037 Assistance Listing Number: 93.

110 Due Date for Applications: July 10, 2024 Purpose: The Health Resources and Services Administration (HRSA ) is accepting applications for the fiscal year (FY) 2024 Policy Innovation Program. The purpose of this program is to support innovative city, county, or state-level policy initiatives that improve outcomes and reduce associated health disparities for maternal and child health populations.

Program Objective(s): By the end of year 3, each award recipient will: • Increase by at least 6 the number of cities, counties, and/or states, and MCH stakeholders engaged in developing and implementing policy initiatives for their MCH populations.

HRSA-24-037 MCH PIP ii • Increase by at least 6 the number of new policy initiatives implemented at the city, county, and/or state level that aim to improve outcomes and reduce associated health disparities in • Increase access to technical assistance materials addressing social determinants of health, MCHB priority topics, and emerging Eligible Applicants: These types of domestic organizations may apply: • Non-profit entities, including community- • Institutions of higher education (public, • Tribal governments or organizations 1 See Section III.

1 of this notice of funding opportunity (NOFO) for complete eligibility Anticipated FY 2024 Total Available Funding: Estimated Number and Type of Award(s): Up to 5 competing continuation, new cooperative Estimated Annual Award Amount: Up to $400,000 per award, subject to the availability of appropriated funds Cost Sharing or Matching Required: Period of Performance: September 30, 2024, through September 29, 2027 > 1For awards authorized by 42 U.S.C.

§ 701(a)(2) (Title V, § 501(a)(2) of the Social Security Act), see also 42 CFR § 51a. 3(a). Agency Contacts: Business, administrative, or fiscal issues: Grants Management Specialist Division of Grants Management Operations, OFAM Program issues or technical assistance: Public Health Analyst, Office of Policy and Planning, Maternal and Child Health Bureau Email: mdwyer@hrsa.

gov You (the applicant organization / agency) are responsible for reading and complying with the instructions included in this NOFO and in HRSA Application Guide (Application Guide) . Visit HRSA’s How to Prepare Your Application page for more information. We have scheduled the following webinar: gov.zoomgov.

com/j/1612401433? pwd=RDlPN1QyNm00Y0pSbHd6aWF0MFVkQT0 Attendees without computer access or computer audio can use the following dial-in information: Call-In Number: 1-833-568-8864 We will record the webinar recording. You can access the recording here .

HRSA-24-037 MCH PIP iv I. PROGRAM FUNDING OPPORTUNITY DESCRIPTION ......................................................... 2 1.

PURPOSE .......................................................................................................................... 2 2. BACKGROUND ....................................................................................................................

4 II. AWARD INFORMATION ........................................................................................................ 5 1.

TYPE OF APPLICATION AND AWARD ..................................................................................... 5 2. SUMMARY OF FUNDING ......................................................................................................

7 III. ELIGIBILITY INFORMATION ................................................................................................ 8 1.

ELIGIBLE APPLICANTS ........................................................................................................ 8 2. A COST SHARING OR M ATCHING .........................................................................................

8 3. O THER .............................................................................................................................. 8 IV.

APPLICATION AND SUBMISSION INFORMATION............................................................. 9 1. ADDRESS TO REQUEST A PPLICATION PACKAGE ...................................................................

9 2. CONTENT AND FORM OF A PPLICATION SUBMISSION ............................................................. 9 i.

Project Abstract ...................................................................................................... 14 ii. Project Narrative .....................................................................................................

15 iii. Budget .................................................................................................................... 18 iv.

Budget Narrative ..................................................................................................... 18 v. Attachments............................................................................................................

18 3. UNIQUE ENTITY I DENTIFIER (UEI) AND SYSTEM FOR AWARD M ANAGEMENT (SAM) .............. 19 4.

SUBMISSION DATES AND TIMES ........................................................................................ 21 5. I NTERGOVERNMENTAL REVIEW .........................................................................................

21 6. FUNDING RESTRICTIONS .................................................................................................. 21 V.

APPLICATION REVIEW INFORMATION ............................................................................ 21 1. REVIEW CRITERIA ............................................................................................................

21 2. REVIEW AND SELECTION PROCESS ................................................................................... 25 3.

ASSESSMENT OF RISK ...................................................................................................... 26 VI. AWARD ADMINISTRATION INFORMATION .....................................................................

26 1. AWARD NOTICES ............................................................................................................. 26 2.

ADMINISTRATIVE AND NATIONAL POLICY REQUIREMENTS ................................................... 26 3. REPORTING .....................................................................................................................

28 VII. AGENCY CONTACTS ....................................................................................................... 29 VIII.

OTHER INFORMATION ................................................................................................... 30 APPENDIX: PAGE LIMIT WORKSHEET ................................................................................. 31 HRSA-24-037 MCH PIP 2 ## I.

Program Funding Opportunity Description This notice announces the opportunity to apply for funding under the Maternal and Child Health Policy Innovation Program. Purpose: The purpose of the Maternal and Child Health Policy Innovation Program (MCH PIP) is to support innovative city, county, or state 2-level policy initiatives that improve outcomes and reduce associated health disparities for maternal and child health populations 3.

Successful award recipients will provide technical assistance (TA) to stakeholders 4, including governors’ offices, state legislatures, state and local health officials, and other state and local officials 5 to help them develop and implement policy initiatives that improve outcomes and reduce related health disparities.

Technical assistance will include (1) convening learning communities (LCs) that engage stakeholders (listed above) in addition to community members and people with lived experience and (2) developing and disseminating informational resources such as (but not limited to) policy briefs, webinars, and/or legislation trackers.

Technical assistance for policy initiatives that address social determinants of health 6 (SDOH), such as improving access to quality affordable housing, healthy foods, or transportation, is especially encouraged.

Award recipients will also support TA for cities, counties, and/or states on Maternal and Child Health Bureau (MCHB) priority topics such as maternal and infant mortality and readiness for obstetric emergencies, and emerging MCH issues (recent examples of which include congenital syphilis, environmental health threats, Medicaid redetermination, and vaccine promotion).

• Increase stakeholder capacity to effectively use policy approaches to improve outcomes, reduce drivers of health disparities in MCH, > 2For purposes of brevity, throughout this NOFO, “State” also includes U.S.Territories and Jurisdictions (District of Columbia, Commonwealth of Puerto Rico, Northern Mariana Islands, Guam, American Samoa, U.S. Virgin Islands, Micronesia, Republic of the Marshall Islands, Republic of Palau).

> 3“Maternal and child health” is a general term that refers to mothers, infants, children, and children and youth with special health care needs. > 4Stakeholders is a general term meant to include key MCH personnel who play a pivotal role in maternal and child health programming and policy.

This group could include (but is not limited to) key policy makers at the state, county, or local level or members of an association aimed at improving maternal and child health. > 5This list of stakeholders is meant to highlight examples and not meant to be all inclusive.

> 6Social determinants of health are the conditions in the environments where people are born, live, learn, work, play, worship, and age that affect a wide range of health, functioning, and quality-of-life outcomes and risks. address MCHB priority topics 7, and respond to emerging issues 8 for MCH populations.

• Increase the number of policy initiatives developed to address SDOH, such as improving access to quality affordable housing, healthy foods, or transportation for MCH populations.

• Increase collaboration with award recipients of the Maternal and Child Health Policy Innovation Program, National Organizations of State and Local Officials (NOSLO), and similar HRSA-funded programs to leverage training, technical assistance, and information and data sharing, where feasible.

To meet these goals, the Maternal and Child Health Policy Innovation Program has set the following objectives: • By the end of year 3, each award recipient will: o Increase by at least 6 the number of cities, counties, and/or states, and MCH stakeholders engaged in developing and implementing policy initiatives for their MCH populations.

o Increase by at least 6 the number of new policy initiatives implemented at the city, county, and/or state level that aim to improve outcomes and reduce associated health disparities in MCH. o Increase access to technical assistance materials addressing social determinants of health, such as improved access to quality affordable housing, healthy foods, or transportation; MCHB priority topics; and emerging issues for MCH populations.

Please note that progress on the above objectives is expected over the course of the period of performance. Award recipients will work closely with the HRSA Project Officer to identify appropriate activities to achieve these objectives and report on their progress throughout the duration of the program. For more details, see Program Requirements and Expectations .

> 7The HRSA Project Officer will communicate MCHB’s priority topics, which include emerging issues in MCH, through regular communications with award recipients. > 8“Emerging issues” refers to issues that affect MCH populations at an increased rate, for which there is new knowledge, an increased level of awareness, or new approaches to solving the issue.

In part, through this program, HRSA aims to increase the ability of states and local communities to anticipate, prepare for, and execute timely responses to emerging issues to reduce negative impacts on MCH populations. The Maternal and Child Health Policy Innovation Program is authorized by 42 U.S.C. § 701(a)(2) (§ 501(a)(2) of the Social Security Act).

MCHB’s mission is to improve the health and well-being of America’s mothers, children and families. We carry out our mission by taking a life-course approach to our work, focusing on: • Perinatal/infant health • Children with special health care needs Recent data show opportunities for improvement in overall outcomes, as well as significant and persistent health disparities, in all of these domains.

The U.S. has high rates of maternal mortality compared to other developed countries and these rates are not improving. 9,10 In addition, thousands of women experience severe maternal morbidity each year. 11 ,12 These unexpected outcomes of labor and delivery result in significant short or long-term consequences to an individual’s health.

13 And according to provisional Vital Statistics data, US Infant mortality rates increased in 2022 for the first time in two decades. 14 Significant disparities exist by race, ethnicity, and geography in maternal and infant health outcomes such as maternal mortality, infant mortality, preterm birth, and low birth weight.

15 Health disparities among adolescents persist with rates of substance use, depression, suicide, and experience of violence, among other risk factors and outcomes, varying based on race, ethnicity, gender, education and income, disability, geographic location (e.g., rural or urban), and sexual orientation.

16 ,17 And the prevalence and impact of special health care needs among children and youth varies by race, ethnicity, socioeconomic status, and geography. 18 > 9Tikkanen, Roosa, Munira Z. Gunja, Molly FitzGerlad, and Laurie Zephyrin.

“Maternal Mortality and Maternity Care in the United States Compared to 10 Other Developed Countries. ” The Commonwealth Fund, November 18, 2020. https://doi.

org/10. 26099/411v-9255. > 10 Federally Available Data (FAD) Resource Document (hrsa.

gov) > 11 Maternal-Morality-Report. pdf (aspeninstitute. org) > 12 Declercq, E.

, & Zepyrn, L. (2021, October 28). Severe Maternal Morbidity in the United States: A Primer.

> Commonwealth Fund. https://www. commonwealthfund.

org/publications/issue-briefs/2021/oct/severe-maternalmorbidity-united-states-primer. > https://www. cdc.

gov/reproductivehealth/maternalinfanthealth/severematernalmorbidity. html. > 14 Vital Statistics Rapid Release, Number 33 (November 2023) (cdc.

gov) > 15 Federally Available Data (FAD) Resource Document (hrsa. gov) > 16 https://www. cdc.

gov/healthyyouth/disparities/index. htm > 17 https://www. cdc.

gov/healthyyouth/data/yrbs/pdf/YRBSDataSummaryTrendsReport2019-508. pdf > 18 Ghandour RM, Hirai AH, Kenney MK. (2022) Children and Youth with Special Health Care Needs: A Profile.

Pediatrics, 149(7):e20210561500. The MCH PIP will build capacity among government officials and key stakeholders to use policy approaches to address these disparities.

Numerous studies have estimated that SDOH can be more important than health care or health behaviors in influencing health, accounting for up to 55% of health outcomes, and that sectors outside of health contribute more to population health outcomes than the health sector does.

19 It is important for organizations and stakeholders at the city, county, and state levels who make MCH-related decisions to have access to information and support to help address these issues in MCH populations. MCH PIP award recipients are expected to provide TA on policy initiatives that address SDOH, as well as MCHB priority topics, and emerging issues for cities, counties, and/or states across the country.

MCH PIP award recipients are also expected to engage community members and people with lived experience and to collaborate with other relevant MCHB and HRSA award recipients. The HRSA Maternal and Child Health Bureau (MCHB) administers programs with focus areas in maternal and women’s health, perinatal and infant health, child health, adolescent and young adult health, and children with special health care needs.

Work | MCHB https://mchb. hrsa. gov/about-us/mission-vision-work .

1. Type of Application and Award Application type(s): Competing Continuation, New We will fund you via a cooperative agreement. A cooperative agreement is like a grant in that we award money, but we are substantially involved with program activities.

Aside from monitoring and technical assistance (TA), we also get involved in these ways: • Assisting in the planning, development, and administration of this project. • Working with the award recipient to develop and approve work plan activities. • Monitoring and supporting implementation of the work plan.

• Convening all award recipients virtually at least quarterly to discuss ongoing work, identify areas for coordination and collaboration, and share best practices. > 19 https://www. who.

int/health-topics/social-determinants-of-health#tab=tab_1 • Reviewing and supporting the development and distribution of reports, issue briefs, publications, trainings, or other products funded in part or in whole under the cooperative agreement. • Participating and providing subject matter expertise in meetings, committees, conference calls, and working groups related to the cooperative agreement and its projects.

• Communicating with award recipients on the development of TA materials, including those on MCHB priority topics and emerging issues. • Coordinating with award recipients to identify opportunities to facilitate MCHB leadership interaction with stakeholders.

• Assisting in the establishment of cooperative and collaborative relationships between award recipients and HRSA partners, staff, and subject matter experts as needed to carry out the project. • Leveraging resources across HRSA to develop synergies in programs, identify opportunities to address health disparities, strengthen existing projects, and avoid duplication of efforts.

You must follow all relevant federal regulations and public policy requirements.

In addition, recipients must not use award funds to: • Support or defeat the enactment of legislation before Congress or any State or local legislature or legislative body; • Support or defeat any proposed or pending regulation, administrative action, or order issued by the executive branch of any State or local government; or • Pay the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive order proposed or pending before the Congress or any State government, State legislature or local legislature or legislative body.

20 . Your other responsibilities will include, but are not limited to: • Developing products that are timely, accurate and fact-based. These products cannot contain opinions and/or judgements and will not and cannot be used for lobbying purposes.

• Collaborating with other MCH PIP award recipients and other HRSA program award recipients to coordinate and leverage training, technical assistance, and information sharing, where feasible. > 20 For more information on lobbying prohibitions, please see: Grants Policy Bulletin 2023-02E: Legislative Mandates in Grants Management for FY 2023 found here: https://www. hrsa.

gov/grants/manage-your-grant/policies-regulations-guidance • Collaborating with city, county and state level government officials and other key MCH stakeholders as required. • Meeting with the HRSA Project Officer at the start of the award and throughout the entire period of performance to review current strategies and ensure projects, products, and goals align with HRSA priorities.

• Communicating in a timely manner with the HRSA Project Officer. This requirement includes meeting monthly with the HRSA Project Officer for status check-ins and participating in progress report reviews. • Working closely with the HRSA Project Officer to update the work plan and implement any proposed new activities.

• Being flexible and responsive to shifting priorities and implementation contexts and modifying policy initiatives and/or technical assistance materials (e.g., policy briefs) as needed. • Planning for HRSA leadership and staff to participate in Policy Innovation Program-funded convenings, conferences and other relevant events.

• Consulting with the HRSA Project Officer before scheduling meetings or conferences at which the HRSA Project Officer’s or other HRSA subject matter experts’ attendance may be appropriate. • Providing the HRSA Project Officer with any materials produced under this cooperative agreement to review and provide input. Review should start as part of the concept development and continue through subsequent drafts and final products.

HRSA/MCHB must be referenced as the funding source in all published materials. We estimate up to $2,000,000 will be available each year to fund up to 5 recipients. You may apply for a ceiling amount of up to $400,000 annually (reflecting direct and indirect costs).

The period of performance is September 30, 2024, through September 29, 2027 (3 years). Support beyond the first budget year will depend on: • Satisfactory progress in meeting the project’s objectives • A decision that continued funding is in the government’s best interest Additional funding may become available at HRSA’s discretion, but this is not guaranteed.

Recipients may request supplemental funding at any point in their period of performance to address unique activities that are connected to, but not duplicative of, the funded work plan.

HRSA may choose to support such supplemental projects if HRSA-24-037 MCH PIP 8 funding is available and allocable, the request is reasonable and allowable, sufficient time remains in the budget period to approve the request, and the activities are aligned with HRSA priorities and are not duplicative of work performed by HRSA or other HRSA-funded recipients.

45 CFR part 75 - Uniform Administrative Requirements, Cost Principles, and Audit Requirements for HHS Awards applies to all HRSA awards. If you’ve never received a negotiated indirect cost rate, you may elect to charge a de minimis rate of 10 percent of modified total direct costs (MTDC)*. You may use this for the life of the award.

If you choose this method, you must use it for all federal awards until you choose to negotiate for a rate. You may apply to do so at any time. See Section 4.

1. v. Budget Narrative in the Application Guide .

*Note : One exception is a governmental department or agency unit that receives more than $35 million in direct federal funding. ## III. Eligibility Information These types of domestic organizations may apply: • Non-profit entities, including community-based organizations • Institutions of higher education (public, private) • Tribal governments or organizations 21 2.

A Cost Sharing or Matching Cost sharing or matching is not required for this program. We may not consider an application for funding if it contains any of the following non-responsive criteria: • Exceeds the funding ceiling amount • Fails to satisfy the deadline requirements referenced in Section IV. 4 > 21 For awards authorized by 42 U.S.C.

§ 701(a)(2) (Title V, § 501(a)(2) of the Social Security Act), see also 42 CFR § 51a. 3(a). We will only review your last validated application before the Grants.

gov due date . ## IV. Application and Submission Information 1.

Address to Request Application Package We require you to apply online through Grants. gov . Use the SF-424 workspace application package associated with this notice of funding opportunity (NOFO).

Follow these directions: How to Apply for Grants . If you choose to submit using an alternative online method, see Applicant System-to-System . Note : Grants.

gov calls the NOFO “Instructions. ” 2. Content and Form of Application Submission Application Format Requirements Submit your information as the Application Guide and this program-specific NOFO state.

Do so in English and budget figures expressed in U.S. dollars. There’s an Application Completeness Checklist in the Application Guide to help you. The total number of pages that count toward the page limit shall be no more than 50 pages when we print them.

We will not review any pages that exceed the page limit. Using the pages within the page limit, HRSA will determine eligibility using Section III. Eligibility Information of the NOFO.

These items do not count toward the page limit: • Standard OMB-approved forms you find in the NOFO’s workspace application package • Abstract (standard form (SF) "Project_Abstract Summary”) • Indirect Cost Rate Agreement • Proof of non-profit status (if it applies) If there are other items that do not count toward the page limit, we’ll make this clear in Section IV. 2. vi Attachments .

If you use an OMB-approved form that isn’t in the HRSA-24-037 workspace application package, it may count toward the page limit. HRSA-24-037 MCH PIP 10 Applications must be complete and validated by Grants. gov under HRSA-24-037 before the deadline .

Debarment, Suspension, Ineligibility, and Voluntary Exclusion Certification • When you submit your application, you certify that you and your principals 22 (for example, program director, principal investigator) can participate in receiving award funds to carry out a proposed project.

That is, no federal department or agency has debarred, suspended, proposed for debarment, claimed you ineligible, or you have voluntarily excluded yourself from participating. • If you fail to make mandatory disclosures, we may take an action like those in 45 CFR § 75. 371 .

This includes suspending or debarring you. 23 • If you cannot certify this, you must include an explanation in Attachments 9-12: Other Relevant Documents . (See Section 4.

1 viii “Certifications” of the Application Guide ) Program Requirements and Expectations The Maternal and Child Health Policy Innovation Program (MCH PIP) is designed to support the development and implementation of innovative policy initiatives to improve outcomes and reduce drivers of health disparities in MCH.

Successful award recipients will have experience providing national-level technical assistance to stakeholders who can develop and implement policies, at the city, county, and/or state level, to help improve outcomes and reduce drivers of health disparities in MCH. Some key stakeholders include governors’ offices, state legislatures, state and local health officials, and other state and local officials.

Having a national perspective as well as experience at the city, county and/or state level will be valuable. Applicants who have expertise and experience working at both the national and city, county, and/or state levels will be more likely to succeed when working on this project.

While the aim of this funding opportunity overall is to engage and provide TA to all four stakeholder groups, applicants are expected to conduct policy analysis, build relationships, and provide TA to only one of the following targeted stakeholder groups: 2. State and Local Health Officials 4.

Other State and Local Officials MCH PIP is designed to be flexible and address the priorities and needs of award recipients and their stakeholders throughout the 3-year duration of the program (project > 22 See definitions at eCFR :: 2 CFR 180. 995 -- Principal. and eCFR :: 2 CFR 376.

995 -- Principal (HHS supplement to government- > wide definition at 2 CFR 180. 995). > 23 See also 2 CFR parts 180 and 376 ,31 U.S.C.

§ 3354 , and 45 CFR § 75. 113 . period).

Each successful Maternal and Child Health Policy Innovation Program award recipient is expected to: Engage multiple stakeholders across the nation via learning communities (LCs) and support LC participants in the development and implementation of MCH policy initiatives that will improve outcomes and reduce drivers of health disparities in MCH.

Award recipients are expected to: • Within 6 months of the start of the award, develop detailed implementation plans for LCs and other forms of TA to support stakeholders in developing policy initiatives that improve outcomes and reduce disparities for their MCH populations. • Convene stakeholders via learning communities.

Award recipients should start convening the LCs by the end of the first year and continue until the end of the project period. o Learning communities may vary in order to respond to stakeholder priorities and interests during the three-year award cycle.

However, award recipients are encouraged to incorporate at least one of the following topics into the LCs: Social Determinants of Health: State and local governments can take policy action to address SDOH in MCH populations.

SDOH policy topics may include, but are not limited to: • Quality Affordable Housing: Housing instability has been associated with fair or poor caregiver and child health, maternal depressive symptoms, child lifetime hospitalizations, food insecurity, and foregone medical care. Challenges may include trouble paying rent, overcrowding, evictions, and houselessness.

An LC which develops policy initiatives around access to quality affordable housing would foster innovation and peer learning around safe and stable housing to improve outcomes and reduce disparities in maternal and child health populations. • Safe and affordable transportation, which can impact access to health and social services, jobs, and educational opportunities.

Access to nutritious food that supports healthy development, consistent with evidence-informed Food Is Medicine initiatives at the local, state, or Federal level. Place-based interventions or initiatives. HRSA-24-037 MCH PIP 12 • Emerging Issues in MCH : state and local governments can play a critical role in anticipating, preparing for, and executing timely responses to issues that specifically and uniquely affect MCH populations.

Emerging issues include those for which there is new knowledge, an increased level of awareness, or new approaches to solving the issue. Examples of recent emerging issues include, but are not limited to congenital syphilis, environmental health threats, Medicaid redetermination, and vaccine promotion in light of declining childhood immunization rates.

• Develop (with HRSA’s input) and implement a selection process to determine which cities, counties, states, and/or stakeholders who represent those entities will participate in LCs. • Craft and execute TA plans to support the development, implementation, and sustainability of policy initiatives to improve outcomes and reduce drivers of disparities in MCH populations.

• Conduct standing check-in calls to provide tailored TA with learning community members. At a minimum, these calls are to be conducted quarterly. • Support cross-sector collaboration between LC members and other stakeholders that play a role in affecting maternal and child health.

• Engage community members, including those with lived experience, to inform the development and implementation of policy initiatives. • Engage Title V agencies and directors to identify mutual objectives, responsibilities, partners, and policy levers to help ensure access to an integrated system of quality health care services and supports for women, children, and infants and promote health across the lifespan.

• Convene LC stakeholders in-person at least once per year. These meetings are an opportunity to learn about MCH policy topics and share best practices at the city, county, or state levels that improve outcomes and reduce the drivers of health disparities in MCH. • Develop effective tools and strategies for ongoing outreach, collaboration, clear communication, and information sharing/dissemination with key stakeholders.

• Develop a data collection mechanism to track performance measures and report annually on the progress of policy development initiation and implementation. • Develop technical assistance (TA) products for key stakeholders at the city, county, and/or state levels*.

Award recipients are expected to develop at least 8 TA products/activities (for example, legislation trackers, policy briefs, blogs) HRSA-24-037 MCH PIP 13 each year for LC members and other MCH stakeholders outside of the LCs.

These TA products should inform and educate stakeholders on MCH policy topics and best practices that cities, counties, and/or states are taking to improve outcomes and reduce drivers of health disparities in MCH. At least some of the TA products/activities should be on MCHB and Title V priority topics or emerging issues in MCH and developed in consultation with the HRSA Project Officer.

These TA products should be complementary to the substantive investment in hands-on engagement and support to stakeholders. • Develop and implement a plan to disseminate all TA products to a broad audience of key city, county, and/or state stakeholders. *Note: Award recipients and HRSA Project Officer should be in close communication about TA materials/activities.

HRSA Project Officer needs to approve all TA products/activities before award recipient starts working on product/activity. Minimum number of TA materials/activities may be modified based on emerging issues, and/or necessary response efforts due to a Public Health Emergency.

Support Communication Efforts • Meet monthly with other MCH PIP award recipients and HRSA to coordinate and leverage training, technical assistance, and information sharing, where feasible.

• Support dissemination efforts to amplify impact and raise awareness of MCHB priority topics such as maternal and infant mortality and readiness for obstetric emergencies, emerging issues (recent examples have included congenital syphilis, vaccine promotion, and Medicaid redetermination), and MCHB events and activities, in consultation with the HRSA Project Officer.

• Facilitate the engagement of MCHB leadership with award recipients’ key stakeholders at least once per year, in consultation with the HRSA Project Officer.

Ensure Sustainability beyond Period of Performance • Propose a plan for project sustainability after the period of federal funding ends, focusing on key elements of the project (e.g., those that have been effective in improving practices and outcomes and reducing disparities for MCH populations). Performance Measurement: Measure and track program performance on key activities and program objectives.

• Performance Measurement : recipients are expected to measure and track progress on program goals and objectives outlined in the Purpose Section.

• This includes Discretionary Grants Information System (DGIS) measures, including Health Equity, Technical Assistance (including recipient HRSA-24-037 MCH PIP 14 satisfaction), Partnerships and Collaboration, Guidelines and Policy, Engagement of Persons with Lived Experience, Knowledge Change, and Products and Publications. For more information on these measures, please see the Reporting section.

• Monitoring : recipients are expected to track project-related processes, activities, and milestones, and use data to identify actual or potential challenges to implementation. ## Program-Specific Instructions Include application requirements and instructions from Section 4 of the Application Guide (budget, budget narrative, staffing plan and personnel requirements, assurances, certifications, and abstract).

Also include the following: Use the Standard OMB-approved Project Abstract Summary Form that you’ll find in the